ArticleFrontiers in oncology2021

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers.

Ling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.